Filed: 5/15/2023ACC: 0001104659-23-060814
📋 What this filing means
SAMSARA BIOCAPITAL, LLC filed this quarterly 13F‑HR report disclosing 56 equity positions with a total reported market value of $485.83M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
56
Positions
$485.83M
Total AUM (reported)
66.35M
Total Shares
Allocation by class
COM$403.14M83.0%
COMMON STOCK$28.02M5.8%
SPONSORED ADS$24.92M5.1%
SPONSORED ADR$12.91M2.7%
COM NEW$7.77M1.6%
ADS$4.00M0.8%
SHS$3.42M0.7%
Portfolio Concentration
Top 3$227.06M46.7%
4–10$126.74M26.1%
11–25$94.53M19.5%
Rest$37.50M7.7%
Top 3 weight
46.7%
Top 10 weight
72.8%
Voting Authority Distribution
Total shares with voting rights: 66.35M
Sole
Full voting authority
66.35M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole56
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings56
Rows:
CHINOOK THERAPEUTICS INC
SOLEShares5.16M
TypeSH
Market value$119.50M
24.60%
Sole
5.16M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares4.52M
TypeSH
Market value$70.77M
14.57%
Sole
4.52M
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares4.60M
TypeSH
Market value$36.79M
7.57%
Sole
4.60M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares909.58K
TypeSH
Market value$28.02M
5.77%
Sole
909.58K
Shared
0.00
None
0.00
GRAPHITE BIO INC
SOLEShares8.46M
TypeSH
Market value$20.73M
4.27%
Sole
8.46M
Shared
0.00
None
0.00
RAIN ONCOLOGY INC
SOLEShares2.26M
TypeSH
Market value$19.76M
4.07%
Sole
2.26M
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares686.84K
TypeSH
Market value$16.71M
3.44%
Sole
686.84K
Shared
0.00
None
0.00
ZYMEWORKS INC
SOLEShares1.62M
TypeSH
Market value$14.65M
3.02%
Sole
1.62M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares695K
TypeSH
Market value$13.96M
2.87%
Sole
695K
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares1.41M
TypeSH
Market value$12.91M
2.66%
Sole
1.41M
Shared
0.00
None
0.00
NKARTA INC
SOLEShares2.87M
TypeSH
Market value$10.18M
2.10%
Sole
2.87M
Shared
0.00
None
0.00
HILLEVAX INC
SOLEShares609.86K
TypeSH
Market value$10.08M
2.08%
Sole
609.86K
Shared
0.00
None
0.00
INTERCEPT PHARMACEUTICALS IN
SOLEShares640.69K
TypeSH
Market value$8.60M
1.77%
Sole
640.69K
Shared
0.00
None
0.00
PEPGEN INC
SOLEShares651.05K
TypeSH
Market value$7.96M
1.64%
Sole
651.05K
Shared
0.00
None
0.00
SUTRO BIOPHARMA INC
SOLEShares1.68M
TypeSH
Market value$7.74M
1.59%
Sole
1.68M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares1.69M
TypeSH
Market value$6.52M
1.34%
Sole
1.69M
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares345.29K
TypeSH
Market value$6.16M
1.27%
Sole
345.29K
Shared
0.00
None
0.00
DICE THERAPEUTICS INC
SOLEShares202.77K
TypeSH
Market value$5.81M
1.20%
Sole
202.77K
Shared
0.00
None
0.00
PRIME MEDICINE INC
SOLEShares470.30K
TypeSH
Market value$5.78M
1.19%
Sole
470.30K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares696.17K
TypeSH
Market value$5.63M
1.16%
Sole
696.17K
Shared
0.00
None
0.00
AMRYT PHARMA PLC
SOLEShares304.71K
TypeSH
Market value$4.44M
0.91%
Sole
304.71K
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares360.41K
TypeSH
Market value$4.36M
0.90%
Sole
360.41K
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares80.96K
TypeSH
Market value$4.00M
0.82%
Sole
80.96K
Shared
0.00
None
0.00
ATYR PHARMA INC
SOLEShares1.75M
TypeSH
Market value$3.67M
0.76%
Sole
1.75M
Shared
0.00
None
0.00
LYRA THERAPEUTICS INC
SOLEShares1.78M
TypeSH
Market value$3.57M
0.74%
Sole
1.78M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CHINOOK THERAPEUTICS INCSOLE | COM | 5.16M | SH | $119.50M 24.60% | 5.16M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 4.52M | SH | $70.77M 14.57% | 4.52M | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 4.60M | SH | $36.79M 7.57% | 4.60M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 909.58K | SH | $28.02M 5.77% | 909.58K | 0.00 | 0.00 |
GRAPHITE BIO INCSOLE | COM | 8.46M | SH | $20.73M 4.27% | 8.46M | 0.00 | 0.00 |
RAIN ONCOLOGY INCSOLE | COM | 2.26M | SH | $19.76M 4.07% | 2.26M | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 686.84K | SH | $16.71M 3.44% | 686.84K | 0.00 | 0.00 |
ZYMEWORKS INCSOLE | COM | 1.62M | SH | $14.65M 3.02% | 1.62M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 695K | SH | $13.96M 2.87% | 695K | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | SPONSORED ADR | 1.41M | SH | $12.91M 2.66% | 1.41M | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 2.87M | SH | $10.18M 2.10% | 2.87M | 0.00 | 0.00 |
HILLEVAX INCSOLE | COM | 609.86K | SH | $10.08M 2.08% | 609.86K | 0.00 | 0.00 |
INTERCEPT PHARMACEUTICALS INSOLE | COM | 640.69K | SH | $8.60M 1.77% | 640.69K | 0.00 | 0.00 |
PEPGEN INCSOLE | COM | 651.05K | SH | $7.96M 1.64% | 651.05K | 0.00 | 0.00 |
SUTRO BIOPHARMA INCSOLE | COM | 1.68M | SH | $7.74M 1.59% | 1.68M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 1.69M | SH | $6.52M 1.34% | 1.69M | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 345.29K | SH | $6.16M 1.27% | 345.29K | 0.00 | 0.00 |
DICE THERAPEUTICS INCSOLE | COM | 202.77K | SH | $5.81M 1.20% | 202.77K | 0.00 | 0.00 |
PRIME MEDICINE INCSOLE | COM | 470.30K | SH | $5.78M 1.19% | 470.30K | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 696.17K | SH | $5.63M 1.16% | 696.17K | 0.00 | 0.00 |
AMRYT PHARMA PLCSOLE | SPONSORED ADS | 304.71K | SH | $4.44M 0.91% | 304.71K | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 360.41K | SH | $4.36M 0.90% | 360.41K | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 80.96K | SH | $4.00M 0.82% | 80.96K | 0.00 | 0.00 |
ATYR PHARMA INCSOLE | COM NEW | 1.75M | SH | $3.67M 0.76% | 1.75M | 0.00 | 0.00 |
LYRA THERAPEUTICS INCSOLE | COM | 1.78M | SH | $3.57M 0.74% | 1.78M | 0.00 | 0.00 |
Page 1 of 3